InvestSMART

Oncosil Medical Limited (ASX: OSL) - Announcements

Current share price for OSL : $0.800 0.015 (1.84%)+

ASX company news and announcements for Oncosil Medical Limited (OSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Oncosil Medical Limited (OSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Oncosil Medical Limited (OSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Oncosil Medical Limited (OSL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$29 Change of Director's Interest Notice - Martin Cross 29 May 2020 6:01PM $0.105 $0.800 risen by 661.90%
$29 Change in substantial holding - Daniel Kenny 29 May 2020 6:01PM $0.105 $0.800 risen by 661.90%
$29 Change of Director's Interest Notice - Chris Roberts 29 May 2020 6:01PM $0.105 $0.800 risen by 661.90%
$29 Appendix 3Y - Late Lodgement Notice - Roger Aston 29 May 2020 6:01PM $0.105 $0.800 risen by 661.90%
$29 Appendix 3Y - Late Lodgement Notice - Daniel Kenny 29 May 2020 6:01PM $0.105 $0.800 risen by 661.90%
$29 Appendix 2A 28 May 2020 10:17AM $0.105 $0.800 risen by 661.90%
$29 Ceasing to be a substantial holder 26 May 2020 6:40PM $0.105 $0.800 risen by 661.90%
$29 Entitlement Offer Results and Shortfall Notification 26 May 2020 9:20AM $0.100 $0.800 risen by 700%
$29 Ceasing to be a substantial holder 19 May 2020 4:56PM $0.115 $0.800 risen by 595.65%
$29 Becoming a substantial holder 13 May 2020 1:56PM $0.115 $0.800 risen by 595.65%
$29 Becoming a substantial holder 12 May 2020 5:17PM $0.115 $0.800 risen by 595.65%
$29 OncoSil Entitlement Offer Booklet 12 May 2020 9:20AM $0.115 $0.800 risen by 595.65%
$29 Ceasing to be a substantial holder 8 May 2020 6:22PM $0.105 $0.800 risen by 661.90%
$29 Appendix 2A 8 May 2020 9:26AM $0.110 $0.800 risen by 627.27%
$29 Cleansing Notice 8 May 2020 9:25AM $0.110 $0.800 risen by 627.27%
$29 Allotment of Securities under Institutional Placement 8 May 2020 9:24AM $0.110 $0.800 risen by 627.27%
$29 Proposed issue of Securities - OSL 4 May 2020 9:32AM $0.110 $0.800 risen by 627.27%
$29 Letter to ineligible shareholders 4 May 2020 9:31AM $0.110 $0.800 risen by 627.27%
$29 Cleansing notice 4 May 2020 9:30AM $0.110 $0.800 risen by 627.27%
$29 Investor Presentation 4 May 2020 9:29AM $0.110 $0.800 risen by 627.27%
$29 OncoSil launches Capital Raising 4 May 2020 9:28AM $0.110 $0.800 risen by 627.27%
$29 OncoSil to present at Virtual Health Conference 4 May 2020 9:04AM $0.110 $0.800 risen by 627.27%
$29 OncoSil submits for ASEAN and APAC approvals 4 May 2020 9:03AM $0.110 $0.800 risen by 627.27%
$29 OncoSil appoints Nigel Lange as EMEA President 4 May 2020 9:02AM $0.110 $0.800 risen by 627.27%
$29 Appendix 4C - quarterly 30 Apr 2020 5:09PM $0.110 $0.800 risen by 627.27%

526 - 550 of 816 results

Page 22 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.